Ellian Enigma RF Device
Ellian Corp · Decision date Sep 2, 2026
What did the FDA decide?
FDA's 510(k) record K262364 covers the Ellian Enigma RF Device, submitted by Ellian Corp of Plano, Texas, and assigned to the electrosurgical cutting and coagulation accessories classification under regulation 878.4400, product code GEI, with the General and Plastic Surgery panel. The agency received the traditional premarket notification on July 10, 2026, and issued a substantially equivalent decision on September 2, 2026. The record states that the submission was not reviewed by a third party, was not a combination product, and included no authorized predetermined change control plan.
The available documents indicate that the clearance rests on a comparison of intended use, technological characteristics and performance data against the predicate device VIVACE. Substantial equivalence is a 510(k) clearance rather than a premarket approval, and the record does not establish approval of the device as a PMA. The source material does not provide the specific indications for use, the technological differences from the predicate, or the performance data reviewed, so those details remain unknown from this record.
The public page also lists Julie Summerville as applicant and correspondent contact, and the device classification name as electrosurgical cutting and coagulation accessories. No clinical or efficacy conclusions are drawn here, and the record does not describe any change to an existing cleared device.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262364
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Ellian Corp
- Product code
- GEI
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrosurgical, Cutting & Coagulation & Accessories.
- Applicant
- Ellian Corp
- Product code
- GEI
- FDA device class
- 2
FDA decision timeline
K262364 received
Application receipt date recorded by FDA.
K262364 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Single Pass, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Stryker Instruments | 510(k) clearance | Oct 20, 2026 | FDA | |
| Ethicon Endo-Surgery, LLC | 510(k) clearance | Sep 17, 2026 | FDA | |
| Stryker Instruments | 510(k) clearance | Sep 17, 2026 | FDA | |
| Covidien LLC | 510(k) clearance | Sep 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ellian Corp
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Plano, TX
Sources and methodology
- Original FDA record: K262364
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



